These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15906386)

  • 1. The effect of a 5-HT1A receptor agonist on striatal dopamine release.
    Bantick RA; De Vries MH; Grasby PM
    Synapse; 2005 Aug; 57(2):67-75. PubMed ID: 15906386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
    Graff-Guerrero A; Willeit M; Ginovart N; Mamo D; Mizrahi R; Rusjan P; Vitcu I; Seeman P; Wilson AA; Kapur S
    Hum Brain Mapp; 2008 Apr; 29(4):400-10. PubMed ID: 17497628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.
    Smith GS; Ma Y; Dhawan V; Chaly T; Eidelberg D
    Synapse; 2009 Jan; 63(1):1-6. PubMed ID: 18925655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11C]WAY-100635 and [11C]raclopride.
    Rabiner EA; Gunn RN; Wilkins MR; Sedman E; Grasby PM
    J Psychopharmacol; 2002 Sep; 16(3):195-9. PubMed ID: 12236624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
    Cervenka S; Varrone A; Fransén E; Halldin C; Farde L
    Synapse; 2010 Jun; 64(6):478-85. PubMed ID: 20175222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
    Egerton A; Ahmad R; Hirani E; Grasby PM
    Psychopharmacology (Berl); 2008 Nov; 200(4):487-96. PubMed ID: 18597077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain.
    Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jönsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
    Mol Psychiatry; 2016 Aug; 21(8):1077-84. PubMed ID: 26821979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
    Hagelberg N; Kajander JK; Någren K; Hinkka S; Hietala J; Scheinin H
    Synapse; 2002 Jul; 45(1):25-30. PubMed ID: 12112410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupancy of agonist drugs at the 5-HT1A receptor.
    Bantick RA; Rabiner EA; Hirani E; de Vries MH; Hume SP; Grasby PM
    Neuropsychopharmacology; 2004 May; 29(5):847-59. PubMed ID: 14985704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion.
    Ostergaard SD; Alstrup AK; Gramsbergen JB; Minuzzi L; Pedersen K; Jensen SB; Doudet D; Cumming P
    Synapse; 2010 Jan; 64(1):70-82. PubMed ID: 19768811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.
    Assié MB; Dominguez H; Consul-Denjean N; Newman-Tancredi A
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):441-50. PubMed ID: 16947046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.